Covid-19: Pfizer’s paxlovid is 89% effective in patients at risk of serious illness, company reports

BMJ (Online), 2021-11, Vol.375, p.n2713-n2713 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2021BMJ ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n2713 ;PMID: 34750163

Full text available